Potent Inhibitors of Fibrotic Disease
Scientific Breakthroughs in Fibrosis and Alzheimer's Disease
Potent Inhibitors of Fibrotic Disease
Scientific Breakthroughs in Fibrosis and Alzheimer's Disease
Scientific Breakthroughs in Fibrosis and Alzheimer's Disease
Scientific Breakthroughs in Fibrosis and Alzheimer's Disease
Buto has a unique therapeutic focus, to block pathophysiologic transitions that occur in a number of fibrotic diseases, and in Alzheimer’s disease. Our molecules have demonstrated efficacy in animal and human fibrosis, and in animal models of Alzheimer's disease.
Buto has uniquely in the world developed small molecules that target the Shc protein—no other company has targeted this molecule. Shc is a ‘gatekeeper protein’ that modulates cell differentiation and pathophysiological transitions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.